The present invention relates to Substituted Quinolizine Derivatives of Formula (I): and pharmaceutically acceptable salts thereof, wherein R1 is as defined herein. The present invention also relates to compositions comprising at least one Substituted Quinolizine Derivative, and methods of using the Substituted Quinolizine Derivatives for treating or preventing HIV infection in a subject.
本发明涉及式(I)的取代喹嗪衍
生物:及其药学上可接受的盐,其中R1如本文所定义。本发明还涉及包含至少一种被取代的喹嗪衍
生物的组合物,以及使用被取代的喹嗪衍
生物治疗或预防受试者HIV感染的方法。